Home/Filings/4/0001645113-23-000028
4//SEC Filing

Ben Arye Barak 4

Accession 0001645113-23-000028

CIK 0001645113other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:56 PM ET

Size

7.2 KB

Accession

0001645113-23-000028

Insider Transaction Report

Form 4
Period: 2023-02-28
Ben Arye Barak
General Counsel
Transactions
  • Award

    Ordinary Shares

    2023-02-28+17,75534,907 total
  • Award

    Ordinary Shares

    2023-02-28$76.97/sh+29,531$2,273,00129,531 total
    Exercise: $76.97From: 2024-02-28Exp: 2033-02-27Ordinary Shares (29,531 underlying)
Footnotes (2)
  • [F1]Represents restricted share units that are scheduled to vest in equal installments on each of February 28, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
  • [F2]Options to buy 29,531 ordinary shares will vest and become exercisable in equal installments on each of February 28, 2024, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.

Issuer

NovoCure Ltd

CIK 0001645113

Entity typeother

Related Parties

1
  • filerCIK 0001917165

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:56 PM ET
Size
7.2 KB